Author

D. F. K. Williamson

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:clinical cohort / trial· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Organism:E. coli· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

A. R. A. Anderson· 1 shared C. Harmon· 1 shared D. Crozier· 1 shared D. Nichol· 1 shared D. S. Park· 1 shared E. McClure· 1 shared H. T. Khong· 1 shared J. Brown· 1 shared

Activity by Year

2018-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. R. A. Anderson

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BioengineeringbioRxivSep 1, 2022

A low-cost, open-source evolutionary bioreactor and its educational use

V. Gopalakrishnan, D. Crozier, K. Card…·J. G. Scott

The paper introduces a low-cost, open-source morbidostat for educational use, validated through bacterial resistance experiments and student engagement.

DOI 10.7554/elife.83067

E. coliexperimental assay

𝕏 PostBluesky

Cancer BiologybioRxivJun 18, 2018

The immune checkpoint kick start: Optimization of neoadjuvant combination therapy using game theory

J. West, M. Robertson-Tessi, K. Luddy…·A. R. A. Anderson

The paper develops a mathematical model to optimize neoadjuvant combination therapy for ER+ breast cancer by balancing tumor burden and metastatic potential using game theory.

DOI 10.1200/cci.18.00078

humanclinical cohort / trial

𝕏 PostBluesky